Literature DB >> 20377406

Paradoxical reaction to treatment in 2 patients with severe acute paracoccidioidomycosis: a previously unreported complication and its management with corticosteroids.

Ronaldo C B Gryschek1, Ricardo M Pereira, Adriana Kono, Rosely A Patzina, Antonia T Tresoldi, Maria A Shikanai-Yasuda, Gil Benard.   

Abstract

Paradoxical reactions have never been described in patients with paracoccidioidomycosis or other deep endemic mycoses out of the context of human immunodeficiency virus infection. We describe 2 patients with an acute form of paracoccidioidomycosis who presented with a worsening of their clinical manifestations while on appropriate antifungal treatment. These manifestations were severe and required adjunct corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20377406     DOI: 10.1086/652290

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Paracoccidioidomycosis in people living with HIV/AIDS: A historical retrospective cohort study in a national reference center for infectious diseases, Rio de Janeiro, Brazil.

Authors:  Eduardo Mastrangelo Falcão; Priscila Marques de Macedo; Dayvison Francis Saraiva Freitas; Andréa d'Avila Freitas; Beatriz Grinsztejn; Valdiléa Gonçalves Veloso; Rodrigo Almeida-Paes; Antonio Carlos Francesconi do Valle
Journal:  PLoS Negl Trop Dis       Date:  2022-06-15

2.  Myeloid dendritic cells (DCs) of mice susceptible to paracoccidioidomycosis suppress T cell responses whereas myeloid and plasmacytoid DCs from resistant mice induce effector and regulatory T cells.

Authors:  Adriana Pina; Eliseu Frank de Araujo; Maíra Felonato; Flávio V Loures; Claudia Feriotti; Simone Bernardino; José Alexandre M Barbuto; Vera L G Calich
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

3.  Paracoccidioidomycosis: epidemiological, clinical, diagnostic and treatment up-dating.

Authors:  Silvio Alencar Marques
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

4.  Indoleamine 2,3-dioxygenase controls fungal loads and immunity in Paracoccidioidomicosis but is more important to susceptible than resistant hosts.

Authors:  Eliseu F Araújo; Flávio V Loures; Silvia B Bazan; Claudia Feriotti; Adriana Pina; Alessandra S Schanoski; Tânia A Costa; Vera L G Calich
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

Review 5.  PARACOCCIDIOIDOMYCOSIS TREATMENT.

Authors:  Maria Aparecida Shikanai-Yasuda
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-09       Impact factor: 1.846

6.  Disease Tolerance Mediated by Phosphorylated Indoleamine-2,3 Dioxygenase Confers Resistance to a Primary Fungal Pathogen.

Authors:  Eliseu Frank de Araújo; Flávio Vieira Loures; Cláudia Feriotti; Tania Costa; Carmine Vacca; Paolo Puccetti; Luigina Romani; Vera Lúcia Garcia Calich
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

7.  AhR Ligands Modulate the Differentiation of Innate Lymphoid Cells and T Helper Cell Subsets That Control the Severity of a Pulmonary Fungal Infection.

Authors:  Eliseu F de Araújo; Flávio V Loures; Nycolas W Preite; Cláudia Feriotti; Nayane Al Galdino; Tânia A Costa; Vera L G Calich
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

8.  Lipoxin Inhibits Fungal Uptake by Macrophages and Reduces the Severity of Acute Pulmonary Infection Caused by Paracoccidioides brasiliensis.

Authors:  Laura R R Ribeiro; Flávio V Loures; Eliseu F de Araújo; Cláudia Feriotti; Tânia A Costa; Carlos Henrique Serezani; Sonia Jancar; Vera L G Calich
Journal:  Mediators Inflamm       Date:  2015-10-08       Impact factor: 4.711

9.  Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?

Authors:  Ana Paula Vieira; Maria Angela Bianconcini Trindade; Flávio Jota de Paula; Neusa Yurico Sakai-Valente; Alberto José da Silva Duarte; Francine Brambate Carvalhinho Lemos; Gil Benard
Journal:  BMC Infect Dis       Date:  2017-04-24       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.